Sun Pharma Q2 FY27 Profit Falls 36% Despite Strong Specialty Drug Sales
Sun Pharma's Q2 FY27 profit falls 36% to ₹1,989 crore on exceptional charges, while revenue rises 12% and specialty medicine sales grow 6.9%.




















